Literature DB >> 25101728

Anti-CGRP antibodies for migraine turn industry heads.

Suzanne Elvidge.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25101728     DOI： 10.1038/nbt0814-707a

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  3 in total

1.  Migraine mAbs crowd into late-stage trials.

Authors:  Gunjan Sinha
Journal:  Nat Biotechnol       Date:  2015-07       Impact factor: 54.908

2.  Meningeal blood flow is controlled by H2 S-NO crosstalk activating a HNO-TRPA1-CGRP signalling pathway.

Authors:  Mária Dux; Christine Will; Birgit Vogler; Milos R Filipovic; Karl Messlinger
Journal:  Br J Pharmacol       Date:  2015-06-12       Impact factor: 8.739

Review 3.  The effect and safety of monoclonal antibodies to calcitonin gene-related peptide and its receptor on migraine: a systematic review and meta-analysis.

Authors:  Min Hou; Haiyan Xing; Yongqing Cai; Bin Li; Xianfeng Wang; Pan Li; Xiaolin Hu; Jianhong Chen
Journal:  J Headache Pain       Date:  2017-04-07       Impact factor: 7.277
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.